Training for empathy can improve patient experience and outcomes, enhance the provider experience and reduce burnout. And it will be a competitive advantage in a post-pandemic world.Read More
Tullman discusses joining Transcarent, what differentiates the startup from other consumer-directed companies, and why the new venture’s myth-breaking mission is personal.Read More
Despite the hefty AstraZeneca-Alexion deal, 2020 was considered a slow year in terms of mergers and acquisitions in life sciences. Early activity in the winter signals that 2021 may be a different story.Read More
Powered by Signify Health
In this Innovation Lab interview series, Armbrester discusses the Company’s reach into nearly 1.5 million homes, having an annual R&D budget of $100 million, what he’s expecting in 2021, and more.
One year since COVID-19 arrived, Health Evolution asked participants in its Leadership Committee to share insights about what they envision for the post-pandemic future.Read More
The idea of activating patients to engage in their care, regardless of the technology used, was taking shape before the pandemic. But it has become even more critical in the year since the virus first emerged with many people having skipped critical care services out of fear of contracting COVID-19.Read More
Powered by HEALTH[at]SCALE
In this Innovation Lab interview series, Syed discusses the company’s ‘precision care delivery’ model, demonstrating industry-leading results in reducing costs of care, identifying patients at risk for adverse events, and more.